The Business Research Company’s global market reports are now updated with the latest market sizing
Read More
Boron neutron capture therapy market to reach $0.28B by 2030, driven by precision oncology, targeted cancer therapy, BNCT system advances, and rising clinical adoption.
Read More
Air wave pressure circulation therapy market to reach $1.63B by 2030, driven by home healthcare demand, aging population, and growth in non-invasive rehab devices.
Read More
The responsible AI bias audit platform market is projected to reach $5.68B by 2030, driven by regulatory enforcement, enterprise AI trust, real-time bias detection, and LLM adoption.
Read More
The responsible AI training market is projected to reach $7.1B by 2030, driven by mandatory AI literacy, workforce ethics training, regulated AI deployment, and audit readiness programs.
Read More
The responsible AI governance councils for banks market is set to reach $4.66B by 2030, driven by regulatory mandates, AI oversight, explainability, and enterprise policy adoption.
Read More
The responsible artificial intelligence (AI) reporting packs market is projected to reach $6B by 2030, driven by regulatory disclosure mandates, board-level AI oversight, automated governance dashboards, bias and risk reporting, and enterprise AI compliance integration.
Read More
The responsible artificial intelligence (AI) documentation tools market is projected to reach $6.39B by 2030, driven by AI governance, enterprise compliance, automated model documentation, audit trails, and explainability solutions.
Read More
The responsible AI market is set to reach $10.15B by 2030, driven by AI regulation, enterprise audits, automated monitoring, bias detection, and compliance tools.
Read More
The relief and aid transportation logistics market is projected to reach $135.09B by 2030 at 6.0% CAGR, driven by disaster response, cross-border aid, resilient logistics, and rapid emergency transport systems.
Read More
The release testing for gene therapy market is projected to reach $3.08B by 2030 at 16.5% CAGR, driven by rapid batch release, automated QC, high-sensitivity potency assays, and vector identity testing.
Read More